CA1150169A - Broad host range small plasmid rings as cloning vehicles - Google Patents
Broad host range small plasmid rings as cloning vehiclesInfo
- Publication number
- CA1150169A CA1150169A CA000355182A CA355182A CA1150169A CA 1150169 A CA1150169 A CA 1150169A CA 000355182 A CA000355182 A CA 000355182A CA 355182 A CA355182 A CA 355182A CA 1150169 A CA1150169 A CA 1150169A
- Authority
- CA
- Canada
- Prior art keywords
- plasmid
- nrrl
- pro1600
- dna
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 317
- 238000010367 cloning Methods 0.000 title claims abstract description 37
- 108020004414 DNA Proteins 0.000 claims abstract description 143
- 230000001580 bacterial effect Effects 0.000 claims abstract description 89
- 239000012634 fragment Substances 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 57
- 241000894006 Bacteria Species 0.000 claims abstract description 53
- 230000008569 process Effects 0.000 claims abstract description 43
- 102000053602 DNA Human genes 0.000 claims abstract description 35
- 101100300704 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) queF gene Proteins 0.000 claims abstract description 28
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 24
- 101100112724 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) ccsB gene Proteins 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 8
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 claims description 35
- 229960003669 carbenicillin Drugs 0.000 claims description 35
- 230000003115 biocidal effect Effects 0.000 claims description 26
- 230000002068 genetic effect Effects 0.000 claims description 24
- 239000004098 Tetracycline Substances 0.000 claims description 15
- 230000029087 digestion Effects 0.000 claims description 15
- 229960002180 tetracycline Drugs 0.000 claims description 15
- 229930101283 tetracycline Natural products 0.000 claims description 15
- 235000019364 tetracycline Nutrition 0.000 claims description 15
- 230000009466 transformation Effects 0.000 claims description 15
- 150000003522 tetracyclines Chemical class 0.000 claims description 13
- 230000010076 replication Effects 0.000 claims description 11
- 238000001727 in vivo Methods 0.000 claims description 9
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 241000589516 Pseudomonas Species 0.000 claims description 7
- 230000002776 aggregation Effects 0.000 claims description 7
- 238000004220 aggregation Methods 0.000 claims description 7
- 229940088710 antibiotic agent Drugs 0.000 claims description 7
- 230000032823 cell division Effects 0.000 claims description 7
- 230000021615 conjugation Effects 0.000 claims description 7
- 238000003776 cleavage reaction Methods 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 5
- 230000007017 scission Effects 0.000 claims description 5
- 239000003550 marker Substances 0.000 claims description 4
- 230000026683 transduction Effects 0.000 claims description 3
- 238000010361 transduction Methods 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 102000004533 Endonucleases Human genes 0.000 claims 2
- 108010042407 Endonucleases Proteins 0.000 claims 2
- 241000589151 Azotobacter Species 0.000 claims 1
- 241000588748 Klebsiella Species 0.000 claims 1
- 210000000349 chromosome Anatomy 0.000 abstract description 7
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 2
- 241000364057 Peoria Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 31
- 108091008146 restriction endonucleases Proteins 0.000 description 25
- 238000002474 experimental method Methods 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 19
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 16
- 230000012010 growth Effects 0.000 description 14
- 101100407030 Arabidopsis thaliana PAO2 gene Proteins 0.000 description 13
- 238000012423 maintenance Methods 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 10
- 108020004511 Recombinant DNA Proteins 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
- 229960004452 methionine Drugs 0.000 description 9
- 229960004295 valine Drugs 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 229960000310 isoleucine Drugs 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 6
- 239000013611 chromosomal DNA Substances 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000017105 transposition Effects 0.000 description 6
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 5
- 229930182844 L-isoleucine Natural products 0.000 description 5
- 229930195722 L-methionine Natural products 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 108010072454 CTGCAG-specific type II deoxyribonucleases Proteins 0.000 description 4
- 230000004543 DNA replication Effects 0.000 description 4
- 230000010310 bacterial transformation Effects 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000589776 Pseudomonas putida Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000721 bacterilogical effect Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 235000014705 isoleucine Nutrition 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000557626 Corvus corax Species 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000003578 bacterial chromosome Anatomy 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 238000005549 size reduction Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101000596275 Bacillus subtilis Type II restriction enzyme BglI Proteins 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 244000182625 Dictamnus albus Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 101100183216 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) mcpB gene Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 244000292604 Salvia columbariae Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000006790 cellular biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000030414 genetic transfer Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/12—Methionine; Cysteine; Cystine
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000423778A CA1177420A (en) | 1980-05-08 | 1983-03-16 | Broad host range small plasmid rings as cloning vehicles |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US147,563 | 1980-05-08 | ||
| US06/147,563 US4374200A (en) | 1980-05-08 | 1980-05-08 | Broad host range small plasmid rings as cloning vehicles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000423778A Division CA1177420A (en) | 1980-05-08 | 1983-03-16 | Broad host range small plasmid rings as cloning vehicles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1150169A true CA1150169A (en) | 1983-07-19 |
Family
ID=22522070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000355182A Expired CA1150169A (en) | 1980-05-08 | 1980-06-30 | Broad host range small plasmid rings as cloning vehicles |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4374200A (en, 2012) |
| EP (1) | EP0039743A3 (en, 2012) |
| JP (2) | JPS572299A (en, 2012) |
| AU (1) | AU538600B2 (en, 2012) |
| CA (1) | CA1150169A (en, 2012) |
| DE (1) | DE39743T1 (en, 2012) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4508827A (en) * | 1980-05-08 | 1985-04-02 | Microlife Technics, Inc. | Molecular cloning vectors for use in gram-negative bacteria |
| US4508823A (en) * | 1980-05-08 | 1985-04-02 | Microlife Technics, Inc. | Gene splicing method and products produced therefrom |
| US4508824A (en) * | 1980-05-08 | 1985-04-02 | Microlife Technics, Inc. | Pseudomonas degradation of hydrocarbons |
| JPS58893A (ja) * | 1981-06-25 | 1983-01-06 | Ajinomoto Co Inc | 発酵法によるｌ−イソロイシンの製造法 |
| US4654307A (en) * | 1983-02-17 | 1987-03-31 | The Research Foundation Of State University Of New York | Novel bacteria containing a plasmid having a tRNA code |
| US4567141A (en) * | 1983-04-25 | 1986-01-28 | Microlife Technics, Inc. | Plasmid vectors including Tn904 |
| US4593003A (en) * | 1983-05-19 | 1986-06-03 | Microlife Technics, Inc. | Bacterial method and compositions for isoprenoid degradation |
| EP0185005B1 (en) | 1984-12-10 | 1992-01-22 | Monsanto Company | Insertion of the bacillus thuringiensis crystal protein gene into plant-colonizing microorganisms and their use |
| US4695455A (en) * | 1985-01-22 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of pesticides produced by expression of heterologous genes |
| EP0200708B1 (en) * | 1985-04-30 | 1992-12-30 | Monsanto Company | Plant-colonizing microorganisms containing the toxin gene of b. thuringiensis as a chromosomal insertion |
| JPS63104406U (en, 2012) * | 1986-12-26 | 1988-07-06 | ||
| AU2007352618B2 (en) | 2007-05-02 | 2013-07-18 | Boehringer Ingelheim Animal Health USA Inc. | DNA plasmids having improved expression and stability |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) * | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
-
1980
- 1980-05-08 US US06/147,563 patent/US4374200A/en not_active Expired - Lifetime
- 1980-06-18 AU AU59374/80A patent/AU538600B2/en not_active Ceased
- 1980-06-27 EP EP80103658A patent/EP0039743A3/en not_active Withdrawn
- 1980-06-27 DE DE198080103658T patent/DE39743T1/de active Pending
- 1980-06-30 CA CA000355182A patent/CA1150169A/en not_active Expired
- 1980-10-07 JP JP13943180A patent/JPS572299A/ja active Granted
-
1986
- 1986-01-17 JP JP61006630A patent/JPS61234784A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0158949B2 (en, 2012) | 1989-12-14 |
| JPS6359677B2 (en, 2012) | 1988-11-21 |
| AU538600B2 (en) | 1984-08-23 |
| JPS572299A (en) | 1982-01-07 |
| US4374200A (en) | 1983-02-15 |
| EP0039743A2 (en) | 1981-11-18 |
| EP0039743A3 (en) | 1982-10-27 |
| JPS61234784A (ja) | 1986-10-20 |
| AU5937480A (en) | 1981-11-12 |
| DE39743T1 (de) | 1983-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Olsen et al. | Development of broad-host-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome | |
| KR890003083B1 (ko) | 테트라시클린 내성 유전자를 함유한 플라스미드, 이로 부터 유도된 dna단편, 및 이 dna단편을 함유한 미생물 및 이들의 제조방법 | |
| Lyras et al. | Conjugative Transfer of RP4-oriTShuttle Vectors fromEscherichia colitoClostridium perfringens | |
| CA1150169A (en) | Broad host range small plasmid rings as cloning vehicles | |
| GB2048894A (en) | Plasmid | |
| US4626504A (en) | DNA transfer vector for gram-negative bacteria | |
| EP0057976B1 (en) | a process for cloning the gene coding for a thermostable alpha-amylase into escherichia coli and bacillus subtilis | |
| US4338400A (en) | Co-integrate plasmids and their construction from plasmids of Escherichia and Streptomyces | |
| US4360597A (en) | Streptomyces plasmid and culture | |
| US4340674A (en) | Cointegrate plasmids and their construction from plasmids of Escherichia and Streptomyces | |
| EP0091723A2 (en) | Vector system | |
| US4376164A (en) | Process for preparing broad host range small plasmid rings as cloning vehicles | |
| EP0213898B1 (en) | A host-vector system | |
| US4418194A (en) | DNA Fragments for forming plasmids | |
| US5565333A (en) | Plasmid replication origin increasing the copy number of the plasmid containing the said origin | |
| JP3013008B2 (ja) | 無胞子性菌株バシラス・サチリス ｓｍｓ２７５ | |
| US4401761A (en) | Process for stabilizing plasmids by deletion of DNA | |
| CA1177420A (en) | Broad host range small plasmid rings as cloning vehicles | |
| EP0179025A1 (en) | Method for the production of neutral protease | |
| JPH06501379A (ja) | 新規なクローニング及び／又は発現ベクター、それらの製造方法及びそれらの使用 | |
| JPS5921389A (ja) | クロ−ン化ストレプトマイセス属菌遺伝子 | |
| JPS62181783A (ja) | 好熱性細菌の染色体に組み込まれる特微を有する変異プラスミド | |
| JPH02312590A (ja) | プラスミドｐＴＹ１ | |
| WO1985000185A1 (en) | Cloning vector, method of constructing such, and method of concentrating and purifying product proteins produced by the cloning vector | |
| JPS5945358B2 (ja) | ネオマイシン、カナマイシン耐性を備えた新規なプラスミド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |